Foghorn Therapeutics Inc.: shareholders and insiders

FHTXNASDAQHealthcare · Pharmaceutical Preparations

Price

$1.97

November 16, 2026Market cap $115M

What Ploutos Investor adds for Foghorn Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%1 On a 13DOct 5, 2026 Latest filing
  • Flagship Ventures Fund V, L.P.with 9 more persons
    Share of class27.2%
  • Biotechnology Value Fund L Pwith 9 more persons
    Share of class14.3%
  • FMRwith 1 more person
    Share of class11.6%
  • Deerfield Mgmt, L.P.with 3 more persons
    Share of class8.64%

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-21%
  • Millennium Mgmt (Englander)
    In the quarter+81%
  • Renaissance Technologies
    In the quarter+14%
  • AQR Capital
    In the quarter+103%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 4.18% of its shares outstanding were held short, +14.1% since the report before.

Shares held short
2.46M
4.18%
Since the report before2.15M on Sep 30, 2026
+14.1%
1.2
2.10M
More days to cover thanof 4,578 US-listed companies with enough volume
18%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 1.36M
  • Nov 15, 2023: Shares held short 1.04M
  • Nov 30, 2023: Shares held short 1.03M
  • Dec 15, 2023: Shares held short 994.1K
  • Dec 29, 2023: Shares held short 914.2K
  • Jan 12, 2024: Shares held short 912.6K
  • Jan 31, 2024: Shares held short 1.06M
  • Feb 15, 2024: Shares held short 1.37M
  • Feb 29, 2024: Shares held short 1.25M
  • Mar 15, 2024: Shares held short 1.25M
  • Mar 28, 2024: Shares held short 1.19M
  • Apr 15, 2024: Shares held short 1.18M
  • Apr 30, 2024: Shares held short 1.32M
  • May 15, 2024: Shares held short 1.30M
  • May 31, 2024: Shares held short 1.28M
  • Jun 14, 2024: Shares held short 985.3K
  • Jun 28, 2024: Shares held short 1.09M
  • Jul 15, 2024: Shares held short 1.26M
  • Jul 31, 2024: Shares held short 1.20M
  • Aug 15, 2024: Shares held short 642.4K
  • Aug 30, 2024: Shares held short 1.06M
  • Sep 13, 2024: Shares held short 1.10M
  • Sep 30, 2024: Shares held short 1.20M
  • Oct 15, 2024: Shares held short 1.33M
  • Oct 31, 2024: Shares held short 1.13M
  • Nov 15, 2024: Shares held short 983.5K
  • Nov 29, 2024: Shares held short 887.9K
  • Dec 13, 2024: Shares held short 948.6K
  • Dec 31, 2024: Shares held short 776.8K
  • Jan 15, 2025: Shares held short 841.7K
  • Jan 31, 2025: Shares held short 918.0K
  • Feb 14, 2025: Shares held short 965.3K
  • Feb 28, 2025: Shares held short 1.01M
  • Mar 14, 2025: Shares held short 975.7K
  • Mar 31, 2025: Shares held short 995.7K
  • Apr 15, 2025: Shares held short 1.07M
  • Apr 30, 2025: Shares held short 1.06M
  • May 15, 2025: Shares held short 1.07M
  • May 30, 2025: Shares held short 1.10M
  • Jun 13, 2025: Shares held short 1.47M
  • Jun 30, 2025: Shares held short 1.59M
  • Jul 15, 2025: Shares held short 908.0K
  • Jul 31, 2025: Shares held short 889.1K
  • Aug 15, 2025: Shares held short 881.2K
  • Aug 29, 2025: Shares held short 869.2K
  • Sep 15, 2025: Shares held short 896.0K
  • Sep 30, 2025: Shares held short 929.9K
  • Oct 15, 2025: Shares held short 838.8K
  • Oct 31, 2025: Shares held short 778.1K
  • Nov 14, 2025: Shares held short 863.4K
  • Nov 28, 2025: Shares held short 1.04M
  • Dec 15, 2025: Shares held short 1.14M
  • Dec 31, 2025: Shares held short 1.13M
  • Jan 15, 2026: Shares held short 1.18M
  • Jan 30, 2026: Shares held short 1.21M
  • Feb 13, 2026: Shares held short 1.16M
  • Feb 27, 2026: Shares held short 1.18M
  • Mar 13, 2026: Shares held short 1.28M
  • Mar 31, 2026: Shares held short 1.33M
  • Apr 15, 2026: Shares held short 1.38M
  • Apr 30, 2026: Shares held short 1.36M
  • May 15, 2026: Shares held short 1.34M
  • May 29, 2026: Shares held short 1.47M
  • Jun 15, 2026: Shares held short 1.39M
  • Jun 30, 2026: Shares held short 1.60M
  • Jul 15, 2026: Shares held short 1.54M
  • Jul 31, 2026: Shares held short 1.60M
  • Aug 14, 2026: Shares held short 1.79M
  • Aug 31, 2026: Shares held short 1.97M
  • Sep 15, 2026: Shares held short 1.99M
  • Sep 30, 2026: Shares held short 2.15M
  • Oct 15, 2026: Shares held short 2.46M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading28.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 28.5% of the shares in the reported trades were short sales, against 43.2% in the 14 before.

Last 14 sessionsOct 27, 2026 – Nov 13, 2026
28.5%
The 14 beforeOct 7, 2026 – Oct 26, 2026
43.2%
Change
-14.7 pts
Short sales a dayon average, of 382.8K shares
109.0K
More than atof 3,649 US-listed companies, same days
4%
Median of alleight in ten from 34.6% to 63.4%
50.1%
  • Oct 7, 2026: Short sales 40%
  • Oct 8, 2026: Short sales 46.7%
  • Oct 9, 2026: Short sales 49.4%
  • Oct 12, 2026: Short sales 37.4%
  • Oct 13, 2026: Short sales 47.3%
  • Oct 14, 2026: Short sales 44.7%
  • Oct 15, 2026: Short sales 47.1%
  • Oct 16, 2026: Short sales 50.9%
  • Oct 19, 2026: Short sales 40.1%
  • Oct 20, 2026: Short sales 46.5%
  • Oct 21, 2026: Short sales 37.3%
  • Oct 22, 2026: Short sales 27.8%
  • Oct 23, 2026: Short sales 36.6%
  • Oct 26, 2026: Short sales 30.8%
  • Oct 27, 2026: Short sales 25%
  • Oct 28, 2026: Short sales 29%
  • Oct 29, 2026: Short sales 38.5%
  • Oct 30, 2026: Short sales 27.5%
  • Nov 2, 2026: Short sales 36.4%
  • Nov 3, 2026: Short sales 36%
  • Nov 4, 2026: Short sales 20.8%
  • Nov 5, 2026: Short sales 37.8%
  • Nov 6, 2026: Short sales 20.3%
  • Nov 9, 2026: Short sales 23.5%
  • Nov 10, 2026: Short sales 48.3%
  • Nov 11, 2026: Short sales 27%
  • Nov 12, 2026: Short sales 23.2%
  • Nov 13, 2026: Short sales 18.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.01% The largest weight (IBB)
  • IBBiShares Biotechnology ETF
    Weight in the fund0.01%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

103 Managers, Q2 2026$219M Value of their positions
  • Q3 2025: Managers 88
  • Q4 2025: Managers 93
  • Q1 2026: Managers 106
  • Q2 2026: Managers 103

Institutional investors by quarter

The fund managers holding FHTX, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 103 managers held 44.92M shares, worth $219M. During the quarter 15 opened a position, 18 closed one, 38 added and 25 trimmed.

The largest holders, Q2 2026

  • Flagship Pioneering
    In the quarter
  • Bvf
    In the quarter
  • FMR
    In the quarter-5.6%
  • Deerfield Management
    In the quarter
  • BlackRock
    In the quarter+11%
  • Raymond James Financial
    In the quarter-4.3%
  • Euclidean Capital
    In the quarter
  • Vanguard Capital Management
    In the quarter
  • Geode Capital Management
    In the quarter+7.4%
  • Siren
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Foghorn Therapeutics's filings show?

Who buys and sells is one part of Foghorn Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about FHTX's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold FHTX?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $1.5M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.